The Kenneth S. Warren Institute is a not-for-profit research Institute dedicated to the study of parasitology. Its mission is to facilitate the discovery and development of new therapeutics to alleviate global health problems.
The Institute was founded by Dr. Anthony Cerami, PhD and his daughter Dr. Carla Cerami, M.D.,Ph.D. Dr. Anthony Cerami is a member of the National Academy of Sciences and the Institute of Medicine. He is an inventor on 131 U.S. patents, and the author of over 420 published scientific papers.
The Kenneth S. Warren Institute was originally incorporated in accordance with the New York State Not-for-Profit laws and originally chartered in 1980, under the name of The Drug and Vaccine Development Corporation (DVDC). In response to a U.S. mandate on the industrial sector to contribute more directly to improving public health in emerging nations, the DVDC espoused to pay particular attention to the health problems affecting populations in the developing world, and it sought to promote working the fields of parasitology and tropical medicine. The Kenneth Warren Prize is awarded every year by the Cochrane Organization to a scientist who publishes a Cochrane Review about a health issue in developing countries.
Although the federal impetus waned with subsequent presidential administrations and corporate sponsorship virtually disappeared, the organization’s membership maintained its objectives throughout the years to establish facilities to further its research goals. Its mission is to facilitate the discovery and development of new therapeutics to alleviate the health problems of the world’s poorest people.
In 2001, state-of-the-art facilities were established at the Kitchawan Preserve, a 15-acre (61,000 m2) campus located in Westchester County, New York. The facilities were named to commemorate the lifelong work of one of the founders of the DVDC. Kenneth S. Warren was an esteemed physician and world-renowned leader in the field of tropical medicine.
Kenneth Warren Prize recipients
2000 - Marissa Alejandria, University of the Philippines, Manila, Philippines. Intravenous immunoglobulin for treating sepsis and septic shock. [abstract] and Anelise Lima, Federal University of Pelotas, Brazil. Carbamazepine for cocaine dependence. [abstract]
2001 - Manit Srisurapanont, Chiang Mai University, Thailand. Quetiapine for schizophrenia. [abstract]
2002 - Prathap Tharyan, Christian Medical College, Vellore, India. Electroconvulsive therapy for schizophrenia. [abstract]
2003 - Maurício Silva de Lima, Federal University of Pelotas, Brazil. Antidepressants for cocaine dependence. [abstract]
2004 - George Swingler, University of Cape Town, South Africa. Conjugate vaccines for preventing Haemophilus influenzae type B infections. [abstract]
2005 - Marilla Lucero, Research Institute for Tropical Medicine, Muntinlupa City, Philippines. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age. [abstract]
2006 - Jonathan Ipser, MRC Research Unit for Anxiety and Stress Disorders, University of Stellenbosch, South Africa. Pharmacotherapy for post traumatic stress disorder [abstract].
2007 - Gawrie Galappaththy, Ministry of Health, Colombo, Sri Lanka. Primaquine for preventing relapses in people with Plasmodium vivax malaria [abstract].
2008 - Martin Meremikwu, University of Calabar, Nigeria. Chemoprophylaxis and intermittent treatment for preventing malaria in children [abstract].
2009 - Nandi Siegfried, South African Cochrane Centre, South African Medical Research Council, Tygerberg, South Africa. Male circumcision for prevention of heterosexual acquisition of HIV in men [abstract].
2010 - Prince Christopher, Cochrane Infectious Diseases Group and Christian Medical College, Vellore, India. Antibiotic therapy for Shigella dysentery [abstract].
2011 - Zohra Lassi, Cochrane Pregnancy and Childbirth Group and Aga Khan University Hospital, Karachi, Pakistan. Community based intervention packages for reducing maternal and neonatal morbidity and mortality and improving neonatal outcomes [abstract].
2012 - Don Mathanga, Cochrane Infectious Diseases Group and University of Malawi, Malaria Alert Center, College of Medicine, Blantyre, Malawi. Intermittent preventive treatment regimens for malaria in HIV-positive pregnant women [abstract].
2013 - Charles Okwundu, Cochrane HIV/AIDS Group and Stellenbosch University, Centre for Evidence-Based Health Care, Tygerberg, South Africa. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals [abstract].
2014 - Babalwa Zani, Cochrane Infectious Diseases Group and South African Cochrane Centre, Cape Town, South Africa. Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria [abstract].
The Anthony Cerami Translational Research Award Winners
2013 – Carl Nathan, MD. “A Journey in Science: Promise, Purpose, Privilege.”
2014 – Göran K Hansson, MD, PhD. “A Journey in Science: Medical Scientist in Translation.” 2014 – David J Weatherall, MD, FRCP, FRS. “A Journey in Science: Early Lessons from the Hemoglobin Field.”